CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 300 enrolled
Drug / intervention
Influenza vaccination +2 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03478254
NCT03478254N/ACompleted
CompareCT.gov

Adherence to Guidelines for Influenza, Pneumococcal and Hepatitis B Vaccination in Adult Patients With Type 1 Diabetes Mellitus (AVADI-1).

Jesús Moreno Fernández·observational·Posted Mar 27, 2018·Updated Jan 11, 2021

In Brief

An observational study evaluating Influenza vaccination, Pneumococcal vaccination, and 1 other intervention for Type 1 Diabetes Mellitus. Completed, enrolled 300 participants across 1 site.

Detailed Summary

Observational study about adherence to guidelines for Influenza, Pneumococcal and Hepatitis B Vaccination in adult patients with type 1 Diabetes mellitus.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus
CountriesSpain
CollaboratorsCastilla-La Mancha Health Service, University of Castilla-La Mancha

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMar 27, 2018
Enrollment StartDec 1, 2017
Primary CompletionDec 1, 2018
Study CompletionDec 31, 2018
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 8.3 years ago

Interventions

Influenza vaccinationbiological

Correct influenza vaccination status was considered in the following situation: \- Received at least one Influenza vaccine dose in the last year.

Pneumococcal vaccinationbiological

Correct pneumococal vaccination status was considered if a subject received at least one of the following options: * One pneumococcal conjugate vaccine (PCV) 13 dose in the last year. * One PCV13 dose following a pneumococcal polysaccharide vaccine (PPSV) 23 dose between the following 8 weeks and 12 months. * One PPSV 23 dose in the last 5 years. * One PPSV23 dose in the last 5 years and a second PPSV23 dose at 5 years or PCV13 at 1 year.

Hepatitis B Virus (HBV) vaccinationbiological

Correct Hepatitis B Virus (HBV) vaccination status was considered in the following situation: .- Received at least three consecutive doses of HBV vaccine during six consecutive months.